3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
13
Pancreatic Neoplasms
7
Cholangiocarcinoma
5
Cirrhosis, Familial, with Pulmonary Hypertension
3
Esophageal Neoplasms
2
Biliary Tract Neoplasms
2
Stomach Neoplasms
1
Pathologic Complete Response
1
Pancreatic Cancer Resectable
1
PDAC - Pancreatic Ductal Adenocarcinoma
1
Neoplasms, Second Primary
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Locally Advanced Low Rectal Adenocarcinoma
1
Liver Neoplasms
1
Liver Metastases of Colorectal Cancer
1
Gastroesophageal Junction Cancer
1
Esophageal Squamous Cell Carcinoma
1
Efficacy and Safety
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Neuroendocrine
1
CRC
1
Biliary Cancer Metastatic
1
Appendiceal Neoplasms
1
Adenocarcinoma Of Esophagus
1
Adenocarcinoma
1
Interventions
venetoclax
1
tegafur-gimeracil-oteracil
1
tagraxofusp
1
Surgical Procedures, Operative
1
Radiation
1
Oxaliplatin
1
Observation
1
Neoadjuvant Therapy
1
Magnetic Resonance Imaging
1
Leucovorin
1
Irinotecan
1
Induction Chemotherapy
1
Immunotherapy
1
Immune Checkpoint Inhibitors
1
Folfox protocol
1
Fluorouracil
1
FOLFOXIRI protocol
1
Endoscopy
1
Drug Therapy
1
Colonoscopy
1
Chemoradiotherapy
1
Carboplatin
1
Capecitabine
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Pathologic Complete Response
×
Leucovorin
×
Clear all
NCT07472868
2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3
Not yet recruiting
394 enrolled